Key Points
Nov 8 (Reuters) - The U.S. Food and Drug Administration approved Eli Lilly's (LLY.N) keenly-awaited obesity treatment on Wednesday, introducing a powerful rival to Novo Nordisk's (NOVOb.CO) popular weight-loss therapy Wegovy...
The once-weekly injection, which contains the same active ingredient as Lilly's big-selling type 2 diabetes treatment Mounjaro, will be sold under the brand name Zepbound..
People are eligible for the drug if they have a BMI of at least 30 or higher, as well as for patients with a BMI of 27 if they have at least one weight-related health condition like diabetes or high blood pressure...
The GLP-1 class of drugs like Wegovy, Novo's related Ozempic and Zepbound were originally developed to help control blood sugar in patients with type 2 diabetes but also slow digestion and reduce hunger...
The drug also comes with warnings similar to those for Wegovy, which include the risk of severe gastrointestinal disease, kidney and pancreatitis-related issues, hypersensitivity reactions and suicidal behavior and ideation..
You might be interested in
Novo Nordisk says Wegovy heart benefits due to more than weight loss
11, Nov, 23Novo Nordisk (NOVOb.CO) on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more than weight loss alone, according to new data presented at a major medical meeting on Saturday.
The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival
09, Nov, 23Eli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs.
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
03, Dec, 23Some leading U.S. obesity specialists say they expect Eli Lilly’s (LLY.N) powerful weight-loss drug Zepbound will produce the same or similar heart benefits as Novo Nordisk’s (NOVOb.CO) popular Wegovy as they belong to the same class of medicines.
Lilly weight-loss drug Zepbound gets US, UK approval to rival Wegovy
09, Nov, 23U.S. and UK regulators both gave thumbs up to Eli Lilly's weight-loss treatment. The drugs are the most effective treatments for weight loss approved to date. | Health